A high RDW combined with a low MPV on your blood work typically signals that your body is dealing with some form of chronic inflammation, a nutritional deficiency, or both. RDW (red cell distribution width) measures how much your red blood cells vary in size, while MPV (mean platelet volume) measures the average size of your platelets. When RDW climbs above the normal range of 9.0% to 14.5% and MPV drops below the normal range of 7 to 9 femtoliters, it points to disrupted blood cell production, often driven by an underlying condition that’s putting stress on your bone marrow.
What RDW and MPV Actually Measure
RDW tells you how uniform your red blood cells are. Healthy red blood cells are roughly the same size. When your body starts releasing a mix of normal and abnormally sized cells into your bloodstream, RDW goes up. This happens when your bone marrow is struggling to produce cells efficiently, whether from a lack of raw materials (like iron or B vitamins) or from interference by inflammation.
MPV reflects how large your platelets are on average. Younger platelets tend to be bigger, while older ones shrink. A low MPV means your platelets are smaller than expected, which can indicate your bone marrow isn’t churning out enough fresh platelets to replace the aging ones. It can also mean that inflammatory chemicals in your blood are affecting how platelets are produced and how long they survive.
Why These Two Shift Together
Chronic inflammation is the most common thread connecting high RDW and low MPV. Inflammatory signaling molecules (called cytokines) interfere with your bone marrow in two ways at once. They disrupt the normal growth of red blood cells by blocking the hormone that stimulates red blood cell production, causing immature and irregularly sized red cells to spill into circulation. That raises RDW. At the same time, those cytokines affect platelet production, size, and lifespan, which can push MPV downward.
This pattern has been documented in several inflammatory conditions. In studies of ovarian cancer, for example, RDW was consistently elevated and MPV was consistently decreased compared to healthy controls and patients with benign tumors. Reduced MPV levels have also been found in non-small cell lung cancer, multiple myeloma, and pelvic inflammatory disease. In inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, elevated RDW levels appeared in 63% and 46% of patients, respectively, and both RDW and MPV have been flagged as markers of disease activity in those conditions.
Common Causes of High RDW
The most frequent reasons for elevated RDW are nutritional deficiencies. Iron deficiency is the leading cause, and a high RDW is one way doctors distinguish iron deficiency anemia from other types of anemia (like thalassemia, which tends to have a normal RDW). Deficiencies in vitamin B12 and folate also drive RDW up because they impair the bone marrow’s ability to produce properly sized red blood cells.
Beyond deficiencies, high RDW shows up after blood transfusions (which introduce differently sized cells), in conditions that destroy red blood cells prematurely (hemolysis), and in chronic diseases that cause low-grade, persistent inflammation. Heart failure, kidney disease, liver disease, and various cancers all tend to push RDW higher. In patients on chronic dialysis, each 1-percentage-point increase in RDW was linked to a 54% higher risk of death over one year, and those with RDW above 15.75% had significantly shorter survival times. High RDW has also been identified as a predictor of worse outcomes in heart failure, pulmonary embolism, and acute coronary syndrome.
Common Causes of Low MPV
Low MPV suggests your bone marrow isn’t replenishing platelets at a healthy pace. The list of potential causes is broad:
- Autoimmune diseases like lupus, which can suppress bone marrow function
- Aplastic anemia, where the bone marrow fails to produce enough blood cells overall
- Bacterial or viral infections that temporarily slow platelet production
- Certain cancers that affect the bone marrow directly or through widespread inflammation
- Medications, particularly chemotherapy drugs that suppress bone marrow activity
- Alcohol use disorder, which is toxic to the bone marrow over time
Medications That Can Skew Results
Some drugs can shift these numbers independently of any disease. Chemotherapy drugs are the most well-known culprits: they suppress the bone marrow broadly, which can lower MPV by slowing platelet production and raise RDW by disrupting red blood cell development. Blood thinners like heparin and warfarin, corticosteroids like prednisone, and certain antibiotics can also affect platelet size. If you’ve recently started a new medication and see these changes on your lab work, the drug itself may be part of the explanation.
What This Combination Doesn’t Tell You
High RDW and low MPV together narrow the possibilities, but they don’t point to a single diagnosis. These are nonspecific markers. They tell your doctor that something is disrupting normal blood cell production, most likely involving inflammation or nutritional deficiency, but additional tests are needed to find the root cause. Your doctor will typically look at your complete blood count alongside iron studies, B12 and folate levels, inflammatory markers like C-reactive protein, and possibly imaging or a bone marrow evaluation depending on the clinical picture.
The combination is more useful as a red flag than a diagnosis. It’s particularly valuable because both markers are already included in a standard complete blood count, meaning they add diagnostic information at no extra cost or effort. When both are abnormal in the same direction (RDW up, MPV down), it strengthens the case that a systemic process like chronic inflammation is at work rather than a simple, isolated lab quirk.
Iron Deficiency vs. Chronic Disease Anemia
One of the most practical uses of RDW is distinguishing between two common types of anemia that can look similar on basic blood work. Iron deficiency anemia and anemia of chronic disease both produce small red blood cells, but they behave differently on RDW. Iron deficiency tends to cause a noticeably elevated RDW because the bone marrow produces a wide range of cell sizes as iron stores deplete gradually. Anemia of chronic disease, by contrast, often shows a more modest RDW increase. When low MPV is also present, it leans the picture toward chronic inflammation as the driving force, since the inflammatory cytokines responsible for anemia of chronic disease are the same ones that suppress platelet size.
This distinction matters because the treatments are different. Iron deficiency is corrected with iron supplementation. Anemia of chronic disease improves only when the underlying condition causing the inflammation is addressed. Getting the right diagnosis early saves time and avoids ineffective treatment.